Kathmere Capital Management LLC Makes New $867,000 Investment in Marsh & McLennan Companies, Inc. $MRSH

Kathmere Capital Management LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 4,998 shares of the financial services provider’s stock, valued at approximately $867,000.

Other hedge funds have also made changes to their positions in the company. Numerai GP LLC lifted its position in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after purchasing an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after acquiring an additional 11,648 shares during the period. Sarasin & Partners LLP grew its stake in shares of Marsh & McLennan Companies by 0.9% in the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after purchasing an additional 8,283 shares in the last quarter. CSM Advisors LLC bought a new stake in shares of Marsh & McLennan Companies during the third quarter valued at about $1,180,000. Finally, Brown Brothers Harriman & Co. grew its position in Marsh & McLennan Companies by 26.4% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock valued at $27,444,000 after buying an additional 28,419 shares in the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Trading Up 2.2%

Shares of Marsh & McLennan Companies stock traded up $3.85 on Tuesday, hitting $178.57. The company had a trading volume of 342,447 shares, compared to its average volume of 2,966,870. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $216.32. The stock has a market capitalization of $86.27 billion, a PE ratio of 22.38, a price-to-earnings-growth ratio of 2.60 and a beta of 0.61. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies’s revenue was up 7.6% compared to the same quarter last year. As a group, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on MRSH shares. JPMorgan Chase & Co. dropped their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. Piper Sandler reduced their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Mizuho reduced their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Morgan Stanley reduced their price objective on Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating for the company in a research note on Monday. Finally, Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $199.25.

Insider Activity

In related news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.